SLC30A9 and diffuse large B-cell lymphoma: Consistent with the effects of NAT10 knockout, SLC30A9 knockdown (SLC30A9 KD) also markedly reduced cell proliferation (Figure 6B,C) and arrested cell cycle process (Figure 6D,E) in DLBCL cells.